- US-listed companies
- DermTech, Inc.
- Income statement
DermTech, Inc.DMTK
Market cap
$3.25M
P/E ratio
| 2018/03 | 2019/03 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Revenue | - | - | 3 | 6 | 12 | 15 | 15 |
| Revenue growth (%) | - | - | - | ||||
| Cost of revenue | - | - | 3 | 6 | 11 | 14 | 15 |
| Gross profit | - | - | 0 | -0 | 1 | 1 | 0 |
| Gross margin (%) | - | - | |||||
| Research & development | - | - | 2 | 5 | 16 | 24 | 15 |
| Operating margin (%) | - | - | |||||
| Operating income | -306,243 | -1,978,028 | -18 | -35 | -77 | -118 | -104 |
| Operating expenses | 306,243 | 2 | 18 | 35 | 79 | 119 | 104 |
| Net income | 856,407 | 944,458 | -20 | -35 | -78 | -117 | -101 |
| Net income margin (%) | - | - | |||||
| Earnings per share | - | - | - | - | - | -3.88 | -3.09 |
| Diluted EPS | - | - | - | - | - | -3.88 | -3.09 |